Verastem reported $6.51M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.13B 73M
AstraZeneca AZN:LN 268.26B 35.48B
Curis CRIS:US $ 5.09M 584K
Cytokinetics CYTK:US $ 42.72M 9.65M
Epizyme EPZM:US $ 24.11M 3.09M
Gilead Sciences GILD:US $ 1.36B 274M
Immunogen IMGN:US $ 23.79M 7.14M
Laboratory Of America LH:US $ 486M 21.9M
Novartis NOVN:VX 3.59B 91M
Pfizer PFE:US $ 3.2B 506M
Tg Therapeutics TGTX:US $ 12.64M 7.97M
Verastem VSTM:US $ 6.51M 580K
YTE INCY:US $ 253.28M 43.69M
Ziopharm Oncology ZIOP:US $ 3.43M 76K